Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CF Benzodiazepine related drugs
N05CF04 Eszopiclone
D02624 Eszopiclone (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Sleep Disorder Agents
Sleep Promoting Agents
GABA Receptor Complexes
Eszopiclone
D02624 Eszopiclone (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
112 Hypnotics and sedatives, anxiolytics
1129 Others
D02624 Eszopiclone (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01836 Non-benzodiazepine sedative-hypnotics
D02624 Eszopiclone
DG03202 Hypnotic
D02624 Eszopiclone
DG01567 GABA-A receptor agonist
D02624 Eszopiclone
Metabolizing enzyme substrate
DG02855 CYP2E1 substrate
D02624 Eszopiclone
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D02624 Eszopiclone
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03202 Hypnotic
D02624 Eszopiclone
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D02624 Eszopiclone (JAN/USP/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02624
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D02624
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02624
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02624